Scinovex
article Open Access

Tunicamycin – A born fighter against CORONA

International Journal of Chemical Studies · 2020 · Vol. 8(4) · pp. 10–13
T NehasriM Prashanthi EvangelineB Gopi KrishnaS Yashitha RagaDivyashree KrishnaSK Sana FarhatSathya Babu

Abstract

One of the perilous threat to humans are Viruses. A greater risk of mortality and morbidity in mankind are caused by most of the viruses. Unfortunately, corona virus stood as a monster in the present scenario. The external envelope of the viruses are comprised of proteins namely glycoproteins. The primary target in viral replication is to interrupt the n-glycosidic linkage thereby obstruct the signals from endoplasmic reticulum to the envelope. This particular area has gained more scope in scientific research. The drug namely tunicamycin has grabbed scientist’s attention in prohibition of viral propagation by showing its effect on endoplasmic reticulum resulting in stoppage of the signals, envelope breaking and inhibiting the interactions with cellular membrane.

Machine Learning in BioinformaticsEndoplasmic reticulumTunicamycinVirologyViral envelopeEnvelope (radar)Cell biologyGlycoproteinViral replicationBiologyHuman immunodeficiency virus (HIV)
Citations
0
FWCI
0.00
field-weighted impact
References
12
Percentile
8%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Tunicamycin – A born fighter against CORONA · Scinovex